This research on LOX encompasses the top ten most common tumors globally, with studies on lung cancer (15 documents), breast cancer (69 documents), colorectal cancer (32 documents), prostate cancer (19 documents), stomach cancer (33 documents), liver cancer (43 documents), cervical cancer (6 documents), thyroid cancer (2 documents), and bladder cancer (3 documents), but excludes research on esophageal cancer. This evidence concerns the gene LOX and breast cancer.